SUBSTANCE USE DISORDERS
Clinical trials for SUBSTANCE USE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SUBSTANCE USE DISORDERS trials appear
Sign up with your email to follow new studies for SUBSTANCE USE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach to boost HIV prevention in LGBTQ+ substance users shows promise but study halted
Prevention TerminatedThis study tested a program called ASK-PrEP to help HIV-negative transgender women and men who have sex with men who also have a substance use disorder stay on PrEP (HIV prevention pills or shots). Participants received counseling and text support, with extra help for those strug…
Matched conditions: SUBSTANCE USE DISORDERS
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Prevention
Last updated Jun 16, 2026 12:49 UTC
-
Psilocybin study for meth addiction halted early – only 5 participants
Symptom relief TerminatedThis study looked at whether psilocybin, a psychedelic drug, is safe and practical to use alongside behavioral support for people with methamphetamine use disorder. Only 5 participants were enrolled before the study was stopped early. The main goal was to track serious side effec…
Matched conditions: SUBSTANCE USE DISORDERS
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
New approach to starting addiction treatment avoids withdrawal
Symptom relief TerminatedThis study tested a new method of starting buprenorphine (a medication for opioid use disorder) that avoids the usual withdrawal symptoms. Participants were adults with opioid misuse and chronic pain who were already taking opioids. The study compared starting with tiny doses of …
Matched conditions: SUBSTANCE USE DISORDERS
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 10, 2026 13:25 UTC